跳至主要内容
临床试验/IRCT20170814035697N5
IRCT20170814035697N5已完成1 期

Evaluation of the effect of silymarin on blood sugar profile(FBSand 2hpp ) and HbA1C in patients with type 2 diabetes mellitus

Oroumia University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 65 years(—)
性别
All

入选标准

  • age between 30-65
  • diagnose of diabetics according to WHO criteria FBS>126mg/dl or 2HP>200mg/dl or HbA1c>9%
  • fasting blood glucose less thanmg/dL 250
  • A history of diabetes is more than 1 year old
  • Conscious informed consent to participate in the study

排除标准

  • Insulin therapy
  • Pregnancy and lactation
  • catching for autoimmune diseases and cancer
  • Taking drugs that interfere with the level of plasma glucose
  • Hospitalized or undergoing surgery

研究者

发起方
Oroumia University of Medical Sciences

相似试验

Evaluation of the effect of silymarin on blood sugar... | 临床试验